3000 ORAL Randomised phase III study of capecitabine, oxaliplatin and bevacizumab (CAPOX-B) with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim safety analysis
暂无分享,去创建一个
M. Koopman | F. Erdkamp | J. Tol | G. Creemers | C. Punt | A. Cats | N. Antonini | C. Rodenburg | L. Mol | C. Swart